| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.38 | 0.04 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.37 | 0.04 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.37 | 0.05 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.23 | 0.05 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.05 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |